Devices
This is a temporary meta description for this page :)
Issue
This is a paragraph introducing the dosage form. This should contain some information about the dosage form, development cycles, and commonly used digiM research technniques. No need to discuss the problems, just introduce the reader. The next section will contain the common challenges we help solve has a handful of bulletpoints.
Common Challenges
- Limited techniques to quantify complex particle attributes that drive aerodynamic performance
- Challenges assessing the interaction between carrier and API
- Process and formulation optimization to achieve ideal DPI particle properties
- Woohoo digiM is really cool
- This is a 2nd bullet point
Solution
We’ve established a workflow for direct quantification of all DPI microstructure attributes key to performance. We apply a 3D synchrotron X-ray micro-CT workflow to visualize 1000s of DPI particles in a single scan, ensuring statistical representativeness not possible with other microscopies. For DPIs in particular, synchrotron X-ray provides greater clarity and accuracy for microstructural interactions where lab-based X-ray micro-CT systems can fall short.
Our Workflow
This is a short 1 or 2 sentence description about how our imaging workflow works. Starting from a grayscale image, we segment and quantify any relevant CQA, before taking it a step further and attempting to simulate and predict product performance.
Areas of Support
This is a short 1 or 2 sentence description about how our imaging workflow works. Starting from a grayscale image, we segment and quantify any relevant CQA, before taking it a step further and attempting to simulate and predict product performance.
Heading 1
digiM accelerates pharma development by transforming image data into actionable insights using AI-powered 2D and 3D microstructural analysis tools.
Heading 3
digiM’s cloud and desktop platforms streamline segmentation, simulation, and visualization for tablets, injectables, and lyophilized drug forms.
Heading 5
Our team partners with pharma companies to perform contract image analysis or provide software for internal workflows, tailored to your needs.
Heading 2
Our imaging software and services enable detailed assessments of drug product microstructure, supporting Q3 equivalence and formulation optimization.
Heading 4
We help R&D teams characterize dissolution, particle size, porosity, and structural integrity using advanced image analysis and modeling tools.
Heading 6
digiM bridges imaging, AI, and pharma science to deliver faster, more precise development decisions for generics, injectables, and complex formulations.
Transform Your Program with Microstructure Science
Get started with a drug product digital twin.
Formulations
Studied
